Peptide appearance
Lyophilized form helps protect peptide quality. Peptides are supplied as a dry powder, which may look like a compact "puck" or a lighter powder inside the vial.
Because the peptide is dry, it does not require refrigerated shipping during normal transit, including warm seasonal conditions. For longer storage, follow the storage guidance in the product description.
Appearance can vary. The stated peptide content is checked through third-party analysis.
Read more in the product description.
Solution not bundled
Peptides are delivered as lyophilized powder. This dry form helps preserve peptide quality during storage and transport and does not require refrigerated shipping during normal transit.
To prepare a solution, use a solvent such as Bacteriostatic water. It is sold separately, so add it only when you need it for peptide preparation.
Read more in the product description.
Muscle Growth
CJC-1295 with DAC
In stock
Order within — to ship today
Arrives 26 – 30 November to Europe
CJC-1295 with DAC
88,90 €
DAC-linked GHRH analogue for albumin-binding and extended-exposure pathway studies.
Compound information
Specifications
Molecular profile
- Sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(N-epsilon-maleimidopropionyl)-NH2
- Molecular mass
- 3647.2 g/mol
- CAS number
- 446262-90-4
- Molecular formula
- C165H269N47O46
Material record
- Physical appearance
- White to off-white lyophilized powder
- Solubility
- Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
- Product note
- Albumin-binding GHRH analogue research compound; supplied strictly for research use only.
Research overview
CJC-1295 with DAC
Description of CJC-1295+DAC?
The CJC-1295+DAC peptide was made by ConjuChem Biotechnologies up of the first 29 amino acids of GHRH combined with a DAC supplement that allows to prolong the half-life and duration of action of the peptide CJC-1295. GHRH, the growth hormone releasing hormone, has been modified several times to create analogues that would have similar effects to GHRH, since its use is limited by short duration of action. This particular GHRH analogue was created in an attempt to find a more soluble GH secretagogue that could both be easily produced in large quantities and preserve or prolong the effects of GHRH action in the body. Although CJC-1295+DAC is chemically very similar to other GHRH analogues such as Sermorelin or even more to GRF (1-29), which is the most similar to it, they are not identical. Subcutaneous administration of CJC-1295 caused in healthy adults dose-dependent increase in GH and IGF-1 levels, which was well tolerated and safe.
Overview of Published Research
Studies have confirmed that after a single injection of CJC-1295 it increases growth hormone (GH) levels in mice and also in healthy human adults by about 2-10-times, with GH reaching peak levels approximately 2 hours after administration of the peptide and the effects lasting for six or more days thereafter. GHRH analogue increases also the IGF-1 concentration by 1,5-3-fold for 9-11 days, whereas the half-life was 5,8-8,1 d.
Maintaining the physiological effect on GH release is critical in affecting the maximum concentration of the hormone in the blood without adverse reaction or increased side effects. Unlike other GH secretagogues, CJC-1295 preserves normal physiological growth hormone release with unchanged frequency and magnitude of GH secretory pulses when the peptide is administered. However, basal levels of growth hormone can be increased. The CJC-1295+DAC peptide has been shown in research to preserve the physiological effects of GH on protein synthesis, myocardial function, bone density, hyperplasia, blood sugar, lipid metabolism or hypertrophy.
Research has indicated that the peptide may be of potential interest in the context of normalizing growth issues. Although children with GH deficiency have a good response to GHRH administration, its therapeutical effects are limited because of very short half-life.
Research has indicated that the peptide may be of potential interest in the context of normalizing growth issues. Although children with GH deficiency have a good response to GHRH administration, its therapeutical effects are limited because of very short half-life.
Scientists have found some in vivo and in vitro evidence that ovarian follicular cycle and ovulation is influenced and stimulated by IGF-1 hormones, and probably also by the release of growth hormone. It is for this reason that the CJC-1295 peptide, as well as other GHRH analogues, could be of research interest in the context of inducing ovulation in infertile women. This is suggested by research done back in the early 1990s and confirmed by another that investigated superovulation in animals. Growth hormone and IGF-1 levels rose significantly just during ovulation and exogenous administration of growth hormone secretagogues, such as CJC-1295, induced ovulation. It has also been suggested that the peptide and other GHRH analogues could potentially act on sperm production in men and may be relevant to research into male infertility. Further research will, hopefully, clearly define the precise role of GH in the induction of ovulation, and the minimum dose of GH needed to sensitize the ovary, as well as influences on men infertility.
For laboratory purposes and personal observation only. Not for human consumption.
Laboratory care
Handling
Peptides in transport
Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.
Storage of lyophilized peptides
Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Up to 3 months
- Refrigerated (2–8 °C): Up to 6 months
- Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)
Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.
Storage of reconstituted peptides
Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.
The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Avoid prolonged storage
- Refrigerated (2–8 °C): Typically 4–8 weeks
- Frozen (-20 °C or below): Up to 3–4 months
To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.
Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.
Analytical documentation
Tests
Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 5 mg

98.6%Purity by HPLC
Recorded QC panel
- AssayPeptide Screening 0.1% TFA
- 4.10 mg (± 0.02 mg)
- PurityPeptide Screening 0.1% TFA
- 98.6%
- Identity (FTIR)Peptide Screening 0.1% TFA
- 980 (± 5)
- Identity (RT)Retention time
- 0.997 (± 0.005)
- Bacterial endotoxinUSP 85 / Eur. Ph. 2.6.14
- Less than 0.001 EU/mg
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
Source record
References
M. Ionescu and L. A. Frohman, "Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog," J. Clin. Endocrinol. Metab., vol. 91, no. 12, pp. 4792–4797, Dec. 2006.
Sam L. Teichman et al., „Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults, 91(3):799-805, Epub 2005 Dec 13.
M. Alba et al., "Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse," Am. J. Physiol. Endocrinol. Metab., vol. 291, no. 6, pp. E1290-1294, Dec. 2006.
A. Volpe, G. Coukos, A. Barreca, G. Giordano, P. G. Artini, and A. R. Genazzani, "Clinical use of growth hormone-releasing factor for induction of superovulation," Hum. Reprod., vol. 6, no. 9, pp. 1228–1232, Oct. 1991.
National Center for Biotechnology Information
PubChem Compound Summary: CJC-1295
Authoritative identity record for CJC-1295 with DAC.
PubChem View source ↗Teichman SL, Neale A, Lawrence B, et al. · 2006
Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of growth hormone-releasing hormone, in healthy adults
Primary characterisation of CJC-1295 as a long-acting GHRH analogue.
Journal of Clinical Endocrinology and Metabolism · 10.1210/jc.2005-1536 View source ↗Sackmann-Sala L, Ding J, Frohman LA, et al. · 2009
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects
Primary CJC-1295 study reporting serum-protein profiling.
Growth Hormone and IGF Research · 10.1016/j.ghir.2009.03.001 View source ↗M. Ionescu and L. A. Frohman · 2006
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
J. Clin. Endocrinol. Metab· 2005
Sam L. Teichman et al., „Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults, 91(3):799-805, Epub 2005 Dec 13
M. Alba et al. · 2006
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse
Am. J. Physiol. Endocrinol. MetabA. Volpe, G. Coukos, A. Barreca, G. Giordano, P. G. Artini, and A. R. Genazzani · 1991
Clinical use of growth hormone-releasing factor for induction of superovulation
Hum. ReprodCustomer reviews
Quality products,fast shipping,great refferal plan,only downside is that products in 4 mounths since my first order got more and more expensive ,but overall verry good experience.
Read full review →More than 2 weeks for package dispatch. They promised one free peptide next time. Sent me new tracking number but package still wasn't delivered to fedex. Last package (much much cheaper) was delivered in less than week. I will update if they will send my package. ok,package sent.
Read full review →Extremely satisfied with the product quality and overall experience. The customer service is polite and quick. All recommendations!
Read full review →Great service!
Read full review →Always on time and customer care is super great
Read full review →Fast good, and quality is perfect
Read full review →ordered 3 times now and everything ok every time.
Read full review →Trustworthy site with a huge catalog of products. Been purchasing from them for some time now never got disappointed. I could only recommend them.
Read full review →Great quality product
Read full review →Everything was great, super customer support, honest, reliable
Read full review →Everything ok. With little problem with package, but after contact with Customer Service everything went right. Good quality of products
Read full review →Excellent. Buying peptides online can be nerve wracking! But Adria are very transparent about all the checks and certifications. My experience with them was excellent. Great products at good prices and efficient P&P
Read full review →



